amibegron drug developed sanofiaventis sanofi acts selective agonist adrenergic receptor first orally active agonist developed capable entering central nervous system antidepressant anxiolytic july sanofiaventis announced decided discontinue development article anxiolytic stub help wikipedia expanding ithttpsenwikipediaorgwikiamibegron